Sanofi S.A. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sanofi S.A. with three other
pharmaceutical manufacturers in Europe:
sales of 49.16 billion Swiss Francs [US$49.16 billion]
of which 66%
was Innovative Medicines),
of the United Kingdom
(£30.19 billion [US$39.61 billion]
of which 57%
was Pharmaceuticals), and
based in Germany
(35.02 billion Euro [US$40.81 billion]
of which 48%
was Pharmaceuticals & Biological Products).
During the year ended December of 2017, sales at
Sanofi S.A. were 36.20 billion Euro (US$42.20 billion).
increase of 4.3%
versus 2016, when the company's sales were 34.71 billion Euro.
The sales level in 2017 was fairly close to the level five years ago: in 2012, Sanofi S.A. had sales
of 34.95 billion Euro.
Sales of Vaccines saw an increase
that was more than double the company's growth rate: sales were up
11.4% in 2017, from
4.58 billion Euro to 5.10 billion Euro.